The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: An exploratory study

European Journal of Surgical Oncology

Volumn 41, Issue 4, 2015, Pages 484-492

  Slesser, A A P ^a,b   Khan, F ^a   Chau, I ^a   Khan, A Z ^a   Mudan, S ^a,b   Tekkis, P P ^a,b   Brown, G ^b,c   Rao, S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Hepatic metastases; Synchronous colorectal liver metastases

Indexed keywords

OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; EXPLORATORY RESEARCH; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COLONIC NEOPLASMS; DISEASE COURSE; DISEASE FREE SURVIVAL; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; RECTAL NEOPLASMS; SECONDARY; SURVIVAL RATE; TIME;

AGED; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929940876     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.12.009     Document Type: Article

References (27)

1. Cancer Research UK. Bowel (colorectal) cancerd - UK mortality statistics. [cited 2013 16th May]; Available from: http://info.cancerresearchuk.org/cancerstats/types/bowel/mortality/.
2. Mantke R, Schmidt U, Wolff S, Kube R, Lippert H. Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 2012;38(3):259-65. http://dx.doi.org/10.1016/j.ejso.2011.12.013 [Epub Dec 29].
3. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13(1):51-64. http://dx.doi.org/10.1634/theoncologist.2007-0142.
4. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg: J Soc Surg Aliment Tract 2003;7(1):109-15. [discussion 16-7].
5. Gonzalez HD, Figueras J. Practical questions in liver metastases of colorectal cancer: general principles of treatment. HPB (Oxford) 2007;9(4):251-8. http://dx.doi.org/10.1080/13651820701457992.
6. Sorbye H, Mauer M, Gruenberger T, et al. Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 2012;255(3):534-9. http://dx.doi.org/10.1097/SLA.0b013-3182456aa2.
7. Vassiliou I, Arkadopoulos N, Theodosopoulos T, et al. Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol: WJG 2007;13(9):1431-4.
8. Boostrom SY, Vassiliki LT, Nagorney DM, et al. Synchronous rectal and hepatic resection of rectal metastatic disease. J Gastrointest Surg: J Soc Surg Aliment Tract 2011;15(9):1583-8. http://dx.doi.org/10.007/s11605-011-1604-9 [Epub 2011 Jul 12].
9. Vigano L, Karoui M, Ferrero A, Tayar C, Cherqui D, Capussotti L. Locally advanced mid/low rectal cancer with synchronous liver metastases. World J Surg 2011;35(12):2788-95. http://dx.doi.org/10.1007/s00268-011-1272-7.
10. Mentha G, Roth AD, Terraz S, et al. 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008;25(6):430-5. http://dx.doi.org/10.1159/000184734 [Epub 2009 Feb 12].
11. Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G. MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 2008;191(5):1517-22. http://dx.doi.org/10.2214/AJR.08.1298.
12. Dighe S, Swift I, Brown G. CT staging of colon cancer. Clin Radiol 2008;63(12):1372-9. http://dx.doi.org/10.016/j.crad.2008.04.021 [Epub Aug 22].
13. Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 2008;191(6):1827-35. http://dx.doi.org/10.2214/AJR.08.1004.
14. Tan EK, Ooi LL. Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease. Ann Acad Med Singap 2010;39(9):715-9.
15. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228-47. http://dx.doi.org/10.1016/j.ejca.2008.10.026.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370(9596):1453-7.
17. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 2001;61(5):2207-11.
18. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79(2):315-28.
19. Scheer MG, Stollman TH, Vogel WV, Boerman OC, Oyen WJ, Ruers TJ. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. J Nucl Med: Publ Soc Nucl Med 2008;49(6):887-91. http://dx.doi.org/10.2967/jnumed.107.048371 [Epub 2008 May 15].
20. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer - Journal international du cancer 2006;119(6):1249-53.
21. Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Ruers TJ. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer - Journal international du cancer 2004;112(4):554-9.
22. van der Wal GE, Gouw AS, Kamps JA, et al. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil. Ann Surg 2012;255(1):86-94. [Epub 2011/12/14].
23. de Haas RJ, Adam R, Wicherts DA, et al. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 2010;97(8):1279-89. http://dx.doi.org/10.002/bjs.7106.
24. Vigano L. Treatment strategy for colorectal cancer with resectable synchronous liver metastases: is any evidence-based strategy possible? World J Hepatol 2012;4(8):237-41.
25. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240(6):1052-61. [discussion 61-4].
26. Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012;13(11):1152-60. http://dx.doi.org/10.016/S470-2045(12)70348-0 [Epub 2012 Sep. 25].
27. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006;244(2):254-9.